Litcius/Paper detail

Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study

Dunya Tomic, Jedidiah I Morton, Lei Chen, Agus Salim, Edward W. Gregg, Meda E. Pavkov, Martti Arffman, Ran D. Balicer, Marta Baviera, Elise Boersma-van Dam, Ralph Brinks, Bendix Carstensen, Juliana C.N. Chan, Yiling J. Cheng, Sandrine Fosse‐Edorh, Sonsoles Fuentes, Hélène Gardiner, Hanne Løvdal Gulseth, Romualdas Gurevičius, Kyoung Hwa Ha, Annika Hoyer, György Jermendy, Alexandra Kautzky‐Willer, Ilmo Keskimäki, Dae Jung Kim, Zoltán Kiss, Peter Klimek, Maya Leventer‐Roberts, Chun-Yi Lin, Paz Lopez‐Doriga Ruiz, Andrea O. Y. Luk, Stefan Ma, Manel Mata‐Cases, Dı́dac Mauricio, Stuart J. McGurnaghan, Tomoaki Imamura, Sanjoy K. Paul, Anna Peeters, Santa Pildava, Avi Porath, Cynthia Robitaille, Maria Carla Roncaglioni, Takehiro Sugiyama, Kang-Ling Wang, Sarah H. Wild, Naama Yekutiel, Jonathan E. Shaw, Dianna J. Magliano

2022The Lancet Diabetes & Endocrinology72 citationsDOIOpen Access PDF

Topics & Concepts

Life expectancyDemographyType 2 diabetesMedicinePopulationJurisdictionYears of potential life lostCohortPublic healthGerontologyIncidence (geometry)Diabetes mellitusEnvironmental healthPolitical scienceSociologyInternal medicineEndocrinologyNursingOpticsPhysicsLawDiabetes, Cardiovascular Risks, and LipoproteinsChronic Disease Management StrategiesDiabetes Management and Education
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study | Litcius